CIK 0001674632 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Beta Bionics, Inc.
Sign in to watch- Ticker
- BBNX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475386878
- Phone
- 949-427-7785
- Business address
- 11 HUGHES, IRVINE, CA, 92618
- Former names
- Beta Bionics, Inc
- 4 Open-market sale Chief Medical Officer sold 4,222 shares at $12.61 ($53,227)
- 4 Open-market sale Chief Financial Officer sold 6,676 shares at $12.61 ($84,165)
- 4 Open-market sale President & CEO sold 16,872 shares at $12.61 ($212,707)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Grant or award Director acquired 16,965 shares (grant or award)
- 4 Planned sale Director sold 1,998 shares at $9.95 ($19,880)
- 4 Grant or award Director acquired 16,965 shares (grant or award)
- 4 Grant or award Director acquired 16,965 shares (grant or award)
- 4 Grant or award Director acquired 16,965 shares (grant or award)
- 4 Planned sale Director sold 1,998 shares at an average $10.58 ($21,138)
- 8-K Event Shareholder vote results
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure · Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
Page 4 of 15 · 290 filings